5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for α4β2 nicotinic acetylcholine receptor and wide range of lipophilicity:: Potential probes for imaging with positron emission tomography

被引：51
|
作者：
Zhang, Y [1 ]
Pavlova, OA [1 ]
Chefer, SI [1 ]
Hall, AW [1 ]
Kurian, V [1 ]
Brown, LL [1 ]
Kimes, AS [1 ]
Mukhin, AG [1 ]
Horti, AG [1 ]
机构：
[1] NIDA, Neuroimaging Res Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD 21224 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 10期
关键词：
D O I：
10.1021/jm030432v
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Potential positron emission tomography (PET) ligands with low picomolar affinity at the nicotinic acetylcholine receptor (nAChR) and with lipophilicity (log D) ranging from -1.6 to +1.5 have been synthesized. Most members of the series, which are derivatives of 5-substituted-6-halogeno-A-85380, exhibited a higher binding affinity at alpha4beta2-nAChRs than epibatidine. An analysis, by molecular modeling, revealed an important role of the orientation of the additional heterocyclic ring on the binding affinity of the ligands with nAChRs. The existing nicotinic pharmacophore models do not accommodate this finding. Two compounds of the series, 6-[F-18]-fluoro-5-(pyridin-3-yl)-A-85380 ([F-18]31) and 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-(2- [F-18]-fluoropyridin-5-yl)pyridine) ([F-18]35), were radiolabeled with F-18. Comparison of PET data for [F-18]31 and 2-[F-18]FA shows the influence of lipophilicity on the binding potential. Our recent PET studies with [F-18]35 demonstrated that its binding potential values in Rhesus monkey brain were ca. 2.5 times those of 2-[F-18]FA. Therefore, [F-18]35 and several other members of the series, when radiolabeled, will be suitable for quantitative imaging of extrathalamic nAChRs.
引用
收藏
页码：2453 / 2465
页数：13
相关论文
共 25 条
  • [1] Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors
    Brown, LL
    Kulkarni, S
    Pavlova, OA
    Koren, AO
    Mukhin, AG
    Newman, AH
    Horti, AG
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) : 2841 - 2849
  • [2] 6-Chloro-3-(((1-[11C]methyl)-2-(S)-pyrrolidinyl)methoxy)5-(2-fluoropyridin-4-yl)pyridine([11C]JHU85270), a potent ligand for nicotinic acetylcholine receptor imaging by positron emission tomography
    Gao, Yonjun
    Ravert, Hayden T.
    Holt, Daniel
    Dannals, Robert F.
    Horti, Andrew G.
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (08) : 947 - 951
  • [3] Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist
    Lin, NH
    Gunn, DE
    Li, YH
    He, Y
    Bai, H
    Ryther, KB
    Kuntzweiler, T
    Donnelly-Roberts, DL
    Anderson, DJ
    Campbell, JE
    Sullivan, JP
    Arneric, SP
    Holladay, MW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (03) : 249 - 254
  • [4] Efficient synthesis of 6-chloro-3-((2-(S)azetidinyl)methoxy)-5-((E)-2-(2-[18F]fluoropyridin-4-yl)vinyl)pyridine ([18F]NIDA 52289), a very high affinity radioligand for nicotinic acetylcholine receptors
    Zhang, Y
    Hall, AW
    Horti, AG
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2004, 47 (06): : 385 - 392
  • [5] Synthesis and structure-activity relationships of 5-substituted pyridine analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent cholinergic channel modulator.
    Lin, NH
    Li, YH
    He, Y
    DonnellyRoberts, DL
    Anderson, DJ
    Campbell, JE
    Arneric, SP
    Holladay, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 8 - MEDI
  • [6] Synthesis and structure-activity relationships of 5-substituted pyridine analogues of 3-[2-((S)-pyrrolidinyl)methoxyl pyridine, A-84543:: A potent nicotinic receptor ligand
    Lin, NH
    Li, YH
    He, Y
    Holladay, MW
    Kuntzweiler, T
    Anderson, DJ
    Campbell, JE
    Arneric, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) : 631 - 633
  • [7] Synthesis of 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-(2-[18F]fluoropyridin-4-yl)pyridine ([18F]NIDA 522131), a novel potential radioligand for studying extrathalamic nicotinic acetylcholine receptors by PET
    Zhang, Y
    Horti, AG
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2004, 47 (13): : 947 - 952
  • [8] Radiosynthesis of the α4β2 nicotinic acetylcholine receptor ligand:: 5-((1-[11C]-methyl-2-(S)pyrrolidinyl)methoxy)-2-chloro-3-((E)-2-(2-fluoropyridin-4-yl)vinyl)pyridine
    Ravert, Hayden T.
    Zhang, Yi
    Horti, Andrew
    Dannals, Robert F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (05): : 459 - 462
  • [9] Synthesis and structure-activity relationships of the 6-chloro-5-substituted analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridin A-84543, a potent nicotinic acetylcholine receptor agonist.
    Li, YH
    Lin, NH
    Wagenaar, F
    Lee, E
    He, Y
    Anderson, D
    Kuntzweiler, T
    Americ, SP
    Holladay, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U245 - U245
  • [10] Comparative PET studies of nicotinic acetyl-choline receptors using 2-and 6-[18F]fluoro-3-(2-(S)-azetidinyl- methoxy)pyridine.
    Ding, YS
    Liu, N
    Logan, J
    Garza, V
    Shea, C
    MacGregor, R
    Fowler, JS
    Volkow, ND
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 212P - 212P
123